Caribou Biosciences CRBU
NASDAQ CRBU
$1.66 +0.05 (+3.11%)
At close: Aug 21, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Selling, General & Administrative (2020 - 2026)

Caribou Biosciences (CRBU) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.13 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 216.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 593.21 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 347.92 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -196.26 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 247.47 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 161.89 Mn
10 Caribou Biosciences 166.63 Mn 54.31 Mn - 7.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 7.90 Mn
Mar 31, 2026 8.07 Mn
Dec 31, 2025 8.58 Mn
Sep 30, 2025 9.20 Mn
Jun 30, 2025 10.40 Mn
Mar 31, 2025 9.74 Mn
Dec 31, 2024 10.49 Mn
Sep 30, 2024 9.84 Mn
Jun 30, 2024 11.49 Mn
Mar 31, 2024 14.64 Mn
Dec 31, 2023 9.72 Mn
Sep 30, 2023 9.71 Mn
Jun 30, 2023 10.12 Mn
Mar 31, 2023 8.91 Mn
Dec 31, 2022 8.53 Mn
Sep 30, 2022 9.85 Mn
Jun 30, 2022 10.04 Mn
Mar 31, 2022 9.59 Mn
Dec 31, 2021 7.85 Mn
Sep 30, 2021 6.76 Mn